Posted by Michael Wonder on 05 Aug 2019
Eli Lilly confirms probe by New York’s Attorney General over insulin prices
2 August 2019 - Eli Lilly has been hit with a subpoena from the New York Attorney General’s Office over the pricing and sales of its insulin products, the drug maker disclosed in a filing.
Attorney general offices in Mississippi, Washington D.C., California, Florida, Hawaii, and Nevada are also seeking information on its pricing, Eli Lilly said in the filing. It also received a civil investigative demands from attorney general offices in Washington and New Mexico.
Eli Lilly did not respond to requests for comment.
